Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate [4]

Annals of the Rheumatic Diseases

Volumn 61, Issue 8, 2002, Pages 756-757

  Rozin, A ^a   Schapira, D ^a   Balbir Gurman, A ^a   Braun Moscovici, Y ^a   Markovits, D ^a   Militianu, D ^a   Nahir, M A ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; ANTIRHEUMATIC AGENT;

ADULT; AGED; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; INFUSION; MIDDLE AGED; NOTE; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMAN; INFUSIONS, PARENTERAL; MALE; METHOTREXATE; MIDDLE AGE; RECURRENCE; HUMANS; MIDDLE AGED;

EID: 0035997498     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.8.756     Document Type: Letter

References (10)

1. Is parenteral methotrexate worth trying?
2. Intramuscular methotrexate in inflammatory rheumatic disease
3. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis
4. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis
5. Pharmacokinetics of methotrexate in rheumatoid arthritis: Therapeutic implications
6. Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis
7. Pharmacokinetics of subcutaneous methotrexate
8. A comparison of low dose methotrexate bioavailability: Oral solution, oral tablet, subcutaneous and intramuscular dosing
9. The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis
10. Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis